TUTakafumi Utsunomiya

Takafumi Utsunomiya

*This is an algorithmically generated author record based on publicly available information.

Takafumi Utsunomiya has a total of 65 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Time‐Lapse Culture Improves Development and Pregnancy Outcomes of Sibling Normally Fertilized Oocytes: A Prospective Multicenter Study

    by Yasuyuki Mio, Takeshi Kuramoto, Takafumi Utsunomiya, Seung Chik Jwa, Keitaro Yumoto, Panagiota Tsounapi

    Purpose: To evaluate whether time‐lapse monitoring improves embryological outcomes and clinical pregnancy rates compared to conventional culture in a sibling‐oocyte study. Methods: This multicenter‐study involved 205 first‐time retrieval cycles ( n = 3244 mature oocytes). Sibling‐oocytes from patients with ≥ 4 oocytes were randomized into conventional and time‐lapse groups. The primary outcome was the good‐quality blastocyst rate. Key secondary outcomes included Day‐2 Good Quality Embryo (GQE) rates and clinical pregnancy rates for both fresh and frozen–thawed embryo transfers (FET). Results: The time‐lapse group exhibited a significantly higher GQE rate on Day 2 (42.1% vs. 35.3%, p < 0.01) and a higher good‐quality blastocyst rate (44.1% vs. 38.1%, p < 0.01) compared to the conventional group. While clinical pregnancy rates showed a higher trend in the time‐lapse group for both fresh ET (44.4% vs. 15.8%) and FET (45.3% vs. 36.7%), these differences did not reach statistical significance. Time‐lapse monitoring successfully identified embryos with early pronuclear disappearance as early as 14 h post‐insemination. Morphokinetic analysis revealed that abnormal cleavage patterns were associated with significantly lower blastocyst development potential compared to normal cleavage ( p < 0.01). Conclusion: Time‐lapse culture provides a stable environment that enhances embryo quality. While clinical pregnancy rates showed a positive trend, further large‐scale studies are needed to confirm the impact on live birth rates.

  • Open Access

    Anthropometric measurements of term singletons at 6 years of age born from fresh and frozen embryo transfer: A multicenter prospective study in Japan

    by Keiko Ueno, Junya Kojima, Kohta Suzuki, Akira Kuwahara, Yasuhiko Higuchi, Atsushi Tanaka, Takafumi Utsunomiya, Yasuyuki Mio, Hirotaka Nishi, Yasunori Yoshimura, et al.

    Purpose: The purpose of this study is to compare anthropometric measurements between term singletons conceived via fresh embryo transfer (FreET) and frozen embryo transfer (FET) and those born via natural conception (NC) or fertility treatments milder than assisted reproductive technology (non‐ART) at 6 years of age.Methods: A total of 8149 children were enrolled, and questionnaires about anthropometric measures (weight, height, BMI) were addressed to parents, when the children were 1.5, 3, and 6 years of age. A total of 3299 term singletons were enrolled at birth: 533, 476, 916, and 1374 in the NC, non‐ART, FreET, and FET groups, respectively.Results: A total of 1635 term singletons (290, 176, 467, and 702 in the NC, non‐ART, FreET, and FET groups respectively) were enrolled until 6 years of age (follow‐up rate, approximately 50%). When non‐ART group was used as control, the FreET children were 1.0 cm taller than the non‐ART children at 6 years of age, after adjusting for confounding factors. However, no differences were observed in the anthropometric data among the non‐ART, ART, and NC children at 6 years of age.Conclusion: At 6 years of age, term singletons were taller in the FreET group than in the non‐ART group, after adjusting for confounders.


  • Open Access

    Creation, effects on embryo quality, and clinical outcomes of a new embryo culture medium with 31 optimized components derived from human oviduct fluid: A prospective multicenter randomized trial

    by Takafumi Utsunomiya, Tatsuma Yao, Hiroko Itoh, Yufuko Kai, Yoko Kumasako, Miwa Setoguchi, Naomi Nakagata, Hiroyuki Abe, Motoharu Ishikawa, Koichi Kyono, et al.

    Purpose: Our aim is to make an ideal embryo culture medium close to human oviduct fluid (HOF) components, and to evaluate the quality of this medium with embryo quality and clinical outcomes in assisted reproductive technology (ART) by a prospective randomized controlled trial (RCT).Methods: Study I: HOF was collected laparoscopically from patients (n = 28) with normal pelvic findings. According to HOF analysis results, the new medium “HiGROW OVIT®” (OVIT) was designed. Study II: Embryos (2 pronuclei (2PN) = 9633) were assigned from 1435 patients. The blastulation rate (BR), good BR (gBR), utilized (transferred/cryo‐preserved) BR (uBR), pregnancy rate (PR), and miscarriage rate (MR) were compared between the OVIT and control groups by RCT.Results: The novel medium ‘OVIT’ was produced according to 31 HOF components. The concentrations of essential amino acids (e‐AAs) were lower in OVIT than in current media, yet the opposite was true for ne‐AA concentrations. gBR and uBR were higher in the OVIT group than in the control group. In the older female group, gBT and uBR were significantly higher in the OVIT group.Conclusions: The novel medium ‘OVIT’ was produced according to HOF data. The OVIT had significantly better embryo quality and clinical outcomes than the current media.


  • Open Access

    Usefulness of combined NGS and QF‐PCR analysis for product of conception karyotyping

    by Takema Kato, Shunsuke Miyai, Hideki Suzuki, Yuuri Murase, Shiyo Ota, Hiroko Yamauchi, Michiko Ammae, Tatsuya Nakano, Yoshiharu Nakaoka, Tomoko Inoue, et al.

    Purpose: Since chromosomal abnormalities can be detected in more than half of miscarriages, cytogenetic testing of the product of conception (POC) can provide important information when preparing for a subsequent pregnancy. Conventional karyotyping is the common diagnostic method for a POC but can be problematic due to the need for cell culture.Methods: We here conducted shallow whole‐genome sequencing (sWGS) using next‐generation sequencing (NGS) for alternative POC cytogenomic analysis. Since female euploidy samples can include 69,XXX triploidy, additional QF‐PCR was performed in these cases.Results: We here analyzed POC samples from miscarriages in 300 assisted reproductive technology (ART) pregnancies and detected chromosomal abnormalities in 201 instances (67.0%). Autosomal aneuploidy (151 cases, 50.3%) was the most frequent abnormality, consistent with prior conventional karyotyping data. Mosaic aneuploidy was detected in seven cases (2.0%). Notably, the frequency of triploidy was 2.3%, 10‐fold lower than the reported frequency in non‐ART pregnancies. Structural rearrangements were identified in nine samples (3%), but there was no case of segmental mosaicism.Conclusions: These data suggest that NGS‐based sWGS, with the aid of QF‐PCR, is a viable alternative karyotyping procedure that does not require cell culture. This method could also assist with genetic counseling for couples who undergoes embryo selection based on PGT‐A data.


  • Open Access

    A questionnaire-based survey to assess patient satisfaction, ease-of-learning, ease-of-use, injection site pain and overall patient satisfaction of the follitropin-alpha (Gonal-f) filled-by-mass (FbM) prefilled pen compared with other systems of gonadotrophin administration

    by Takafumi Utsunomiya, Atsushi Tanaka, Kenichi Tatsumi, Diego Ezcurra

    Background: Gonadotrophins are used routinely for follicular stimulation during ovarian induction and assisted reproduction techniques. Developments in recombinant follicle-stimulating hormone preparations and their injection devices have improved patient quality of life by enabling patients to self-administer treatment at home. The objective of this study was to investigate patient experiences of learning to use and overall satisfaction with the follitropin-alpha (Gonal-f) filled-by-mass (FbM) prefilled pen. Methods: This questionnaire-based survey study was conducted in 23 fertility centres in Japan over a period of 14 months. Patients who were receiving fertility treatment with the follitropin-alpha (FbM) prefilled pen were asked to complete a questionnaire to assess their satisfaction, ease of learning and use, and injection site pain following treatment. Results: A total of 663 women participated in the study. The majority of patients found the instructions for administering follitropin-alpha with the prefilled pen easy to understand (83.0%; n = 546/658) and patients found that a hands-on demonstration by a nurse or doctor was the most useful tool for learning to use the follitropin-alpha (FbM) prefilled pen (80.0%; n = 497/621). Forty-eight percent (n = 318) of patients in the study had previous experience with different types of fertility medications and the majority of these patients found the follitropin-alpha (FbM) prefilled pen easier to use (75.1%; n = 232/309) and less painful (89.0%; n = 347/390) than their previous medication. The majority (80.2%; n = 521/650) of patients reported overall satisfaction with the follitropin-alpha (FbM) prefilled pen. Conclusions: The follitropin-alpha (FbM) prefilled pen is an easy-to-use injection device according to this questionnaire-based survey. Patients who had experience of different types of fertility medication preferred the follitropin-alpha (FbM) prefilled pen to other injection devices.


  • Developmentally retarded frozen blastocysts can be rescued by synchronizing culture prior to transfer

    by Takafumi Utsunomiya, Hiroko Ito, Kaori Hirai, Eiko Otsu, Hirohiko Watanabe, Takahide Mori


  • A prospective, randomized study: day 3 versus hatching blastocyst stage

    by Takafumi Utsunomiya, Hiroko Ito, Miyuki Nagaki, Junko Sato

    BACKGROUND: Recently, advances in human IVF‐embryo transfer (ET) have been reported using sequential media and blastocyst stage ET. In our previous report, using a prospective, randomized study, no advantage was found using the blastocyst stage ET compared with day 3 ET. This study was performed in order to evaluate implantation and pregnancy rates of hatching blastocyst stage ET compared with conventional day 3 ET. METHODS AND RESULTS: A total of 480 patient cycles were evaluated using a prospective, randomized study. The pregnancy rate and implantation rate were compared between the day 3 ET (n = 240) and hatching blastocyst stage ET (Hat ET; n = 240). The Hat ET group had a pregnancy rate of 29.3% (55 out of 188) and an implantation rate of 21.4% (67 out of 313). The day 3 ET group had a pregnancy rate of 29.2% (70 out of 240) and an implantation rate of 19.1% (93 out of 488). In the Hat ET group, the pregnancy rate, implantation rate and ongoing pregnancy rate of day 5 ET and day 6 ET were all higher than the respective rates in the day 7–9 ET group. CONCLUSION: We found that the pregnancy rate and implantation rate of ET with hatching stage blastocysts had no advantage compared with the conventional day 3 ET.


  • Open Access

    A prospective trial of blastocyst culture and transfer

    by Takafumi Utsunomiya, Tae Naitou, Miyuki Nagaki

    BACKGROUND: The aim of this study was to evaluate the effectiveness of the blastocyst culture method compared with the conventional day 3 transfer method using a prospective trial. METHODS: A total of 235 patients with 273 cycles were evaluated for a period of almost 1 year. Depending upon the sequence in which the ovum retrieval was performed, patients were prospectively assigned (alternate allocation) to a culture period of 3 or 5 days duration. Embryos were transferred either on day 3 (after culture in human tubal fluid) or on day 5 (after culture in sequential media). RESULTS: The pregnancy rates after embryo transfer on days 3 and 5 were similar at 26.5 and 25.9% respectively. Among the day 5 embryo transfer group, patients were divided into three groups corresponding to three sequential media. The pregnancy rates were 32.0% using Irvine blastocyst medium, 6.9% using G1.2/G2.2 and 32.4% using Cook blastocyst medium. CONCLUSIONS: The results of our study were not as successful as previous studies had been. Additionally, there may have been problems in day 5 embryo transfer, such as choosing the sequential media, quality control, contamination and so on. From the results of this study, it appears that day 5 embryo transfer has no advantages for ordinary patients of assisted reproductive technology.